Related Experiment Video
Updated: Dec 31, 2025

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
Published on: March 1, 2024
C reactive protein testing in general practice safely reduces antibiotic use for flare-ups of COPD
Rob Cook1, Johnny Lyon-Maris2, Alicia White1
1Bazian, Economist Intelligence Unit healthcare, London, UK.
Abstract:
The studyButler CC, Gillespie D, White P, et al. C-reactive protein testing to guide antibiotic prescribing for COPD exacerbations. N Engl J Med 2019;381:111-20.This research was funded by the NIHR Technology Assessment Programme (project number 12/33/12). The testing machines used in the study were loaned to researchers by the manufacturer, who also provided training on their use. The manufacturer had no other role in any part of the trial.To read the full NIHR Signal, go to https://discover.dc.nihr.ac.uk/content/signal-000820/crp-testing-safely-reduces-antibiotic-use-for-copd-flare-ups.
More Related Videos
Related Concept Videos
Pneumonia III: Complications and Assessment
COPD: Management Using Bronchodilators and Corticosteroids
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Chronic Obstructive Pulmonary Disease-I: Introduction
Rheumatic Heart Disease III: Medical Management
Pericarditis II: Clinical Features and Diagnostic Tests

